1. Introduction {#sec1}
===============

Pseudomembranous tracheitis (PMT) is a rare condition most commonly caused by fungal or bacterial infection that is characterized by a pseudomembrane that partially or completely covers the tracheobronchial tree. PMT is most often found in immunocompromised patient populations, such as post-chemotherapy, AIDS, post-transplant, and hematological malignancies [@bib1], [@bib2]. Fungal infections of the trachea can cause this rare phenomenon which may potentially lead to necrosis [@bib3]. The pathogens known to cause this pseudomembranous infection are: *Aspergillus, Candida, Cryptococcus, Rhizopus, and Mucorales* [@bib4], [@bib5]. In more rare cases, pseudomembranous tracheitis may be caused by invasive bacterial pathogens such as *Bacillus cereus* [@bib6]. PMT should be considered in the differential diagnosis of refractory cough in the immunocompromised population. However, it has been described in patients with nonspecific respiratory symptoms such as dyspnea, cough, and other airway issues [@bib7]. Herein, we present a case of pseudomembrane tracheitis in the setting of high grade T-cell lymphoma.

2. Case report {#sec2}
==============

A 65 year old male with a past medical history of non-obstructive coronary artery disease, urothelial cancer (status post resection), abdominal aortic aneurysm (status post repair), hypothyroidism, and 50 pack-year history of smoking, was admitted presenting with recurring fevers and a 30-pound weight loss over the past several months. A Chest x-ray (CXR) revealed a right mid-lung consolidation. Computer tomography (CT) showed a left supraclavicular/lower cervical mass, hilar lymphadenopathy as well as enlargement of the subcarinal and mediastinal lymph nodes. Subsequent lymph node biopsy revealed high grade T-cell lymphoma.

The patient was started up on empiric antibiotic therapy but continued to be febrile. He subsequently underwent bronchoscopy which revealed a pseudomembrane extending from the bronchus intermedius down to the right lower lobe ([Fig. 1](#fig1){ref-type="fig"}). Bronchoscopy was negative for any masses, abscesses, erosions or areas of bleeding.Fig. 1Bronchoscopy shows mucous-like layer in the bronchotrachial tree. A) Right upper lobe apico-posterior B) Bronchus intermedius C) Secondary carina right side.Fig. 1

Both an endobronchial biopsy as well as culture of the bronchioalveolar lavage revealed *Aspergillus fumigatus* ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2Microscopic view of biopsy shows strains of *Aspergillus fumigatus* with characteristic hyphae.Fig. 2

Patient was initiated on Voriconazole. Repeat bone marrow biopsy was negative for Aspergillus. The patient was discharged on Voriconazole and oxygen. Despite treatment the patient died of progressive pulmonary infiltrates and respiratory failure.

3. Discussion {#sec3}
=============

Pseudomembranous tracheitis (PMT) is commonly caused by fungal or bacterial infection that is characterized by pseudomembrane formation in the large airways [@bib1], [@bib2]. Here we described a case of a 65-year-old male with undiagnosed malignancy that had developed Aspergillus-related PMT. PMT is a rare condition that manifests with different symptoms and etiologic microorganisms. Previously reported cases of PMT have been outlined in [Table 1](#tbl1){ref-type="table"}.Table 1Cases of PMT.Table 1AuthorPrimary diseaseCausesOrganismSigns/SymptomsTreatmentOutcomesWilliams et al. [@bib5]LeukemiaStem cell transplantation secondary to pancytopenia*Aspergillus*Progressive cough, nauseaAmphotericin B (IV), Amphotericin B (inhaled), caspofungin (IV)DeceasedStrauss et al. [@bib6]UnknownAplastic Anemia*Bacillus cereus*Petechiae, weakness, dyspneaBroad-spectrum antibiotic, anti-viral, antifungal therapyDeceased (multiple organ failure)Chang et al. [@bib8]Pt. 1: Diabetes mellitus\
Pt. 2: DiabetesDiabetic ketoacidosis\
Diabetic ketoacidosis*Aspergillus*\
*Aspergillus*Chest pain, cough, dyspnea, wheeze\
Non-productive cough, right side chest pain, feverParental amphotericin B\
amphotericin BDeceased (septic shock)\
ImprovedTait et al. [@bib7]Pt. 1:Non-Hodgkin\'s lymphoma\
Pt. 2: Systemic lupus erythematosus-like disorderNeurtopenia\
Neurtopenia*Aspergillus*\
*Aspergillus*Weight loss, anorexia, non-productive cough, and pyrexia\
Weight loss, polyarthralgia, night sweats, pyrexiaamphotericin B\
intravenous amphotericin B (1 mg/kg/day), flucytosine (120 mg/kg/day), and oral itraconazole (600 mg/day) commenced,Deceased\
Deceased (respiratory failure)Hines et al. [@bib9]Pt.1: COPD\
Pt.2: Hodgkin\'s lymphoma\
Pt. 3 Myelodysplastic syndrome\
Pt. 4 Hepatic lesionsRespiratory arrest\
Neutropenia\
Bone marrow transplant\
Neutropenia*Aspergillus*\
*Aspergillus*\
*Aspergillus*\
*Aspergillus*Fever, wheezing\
Fever\
Fever, hypotension\
Epigastric and lower back painVancomycin, Clindamycin, Amikacin\
Amphotericin B\
Amphotericin B\
Broad spectrum antibioticsDeceased\
Deceased (respiratory failure)\
Deceased (progressive respiratory insufficiency)\
DeceasedPornsuriyasak et al. [@bib10]TuberculousTuberculous tracheal stenosisAspergillusFever, Dyspnea, Chest painOral voriconazole Nebulized amphotericin BCuredHuang et al. [@bib11]16 cases:\
56.3% (9/16) Pulmonary malignancies\
31.3% (5/16)\
Bronchial involvement secondary to non-pulmonary tumor\
12.5% (2/16)\
Lung transplant62.5% (10/16)\
Radiotherapy\
43.8% (7/16) Repeated chemotherapy\
25.0% (4/16)\
Recurrent intervention therapy by bronchoscope*Aspergillus*87.5% (14/16)\
Progressive dyspnea\
75.0% (12/16)\
Irritable cough100% Amphotericin B (inhalation and infusion)68.8% (11/16)\
DeceasedPutnam et al. [@bib3]LeukemiaBone marrow transplantation secondary to aplastic anemia*Aspergillus*Weakness, fatigue, dyspneaAmphotericin B (IV)DeceasedPatel et al. [@bib12]LeukemiaPancytopenia*Aspergillus*Shortness of breath, cough, pleuritic chest painAmphotericin B (IV)Deceased (progressive leukemia and sepsis)Williams et al. [@bib5]Type 2 Diabetes and leukemiaallogeneic stem cell trans- plantation.*Rhizopus* sp.Progressive cough, dyspnea, nausea and emesisintravenous liposomal amphotericin B, inhaled amphotericin B, intravenous caspofunginDeceased (respiratory failure)Le et al. [@bib13]Acute lymphoblastic leukemia.chemotherapy*Aspergillus.*Cough, fever, and hoarseness.Intravenous voriconazole\
G-CSFImprovedArgüder et al. [@bib14]Diabetes mellitusInconsistent use of insulin*Aspergillus*Cough, chest pain, hoarseness, fever, dyspnealiposomal amphotericin BDeceasedRamos et al. [@bib15]Cardiac amyloidosisHeart transplant*Aspergillus*Fever, dyspnea, wheezing, and a coughIV voriconazole\
IV caspofunginImprovedShah et al. [@bib16]StillbirthPulmonary edema*Aspergillus*Dyspnea, stridorVoriconazoleImproved, then lost to follow up

Invasive pulmonary aspergillosis (IPA) is the most common form of disease caused by Aspergillus species infection. In addition, a rare form of IPA is an infection of the tracheobronchial tree, called Aspergillus Tracheobronchitis (AT) [@bib17]. Four types of AT: ulcerative tracheobronchitis, obstructive bronchial aspergillosis, aspergillus bronchitis, and pseudomembranous necrotizing bronchial aspergillosis, or PMT have been described [@bib1], [@bib2]. The pseudomembrane is thought to be derived from fibrin, hyphae, and necrotic tissue [@bib12]. Other fungi such as *Rhizopus*, *Cryptococcus* and *Candida* can also form a pseudomembrane via similar mechanisms [@bib4], [@bib5]. Rarely viruses may be implicated in PMT. Known causes of PMT have been outlined in [Table 2](#tbl2){ref-type="table"}.Table 2Causes of Psuedomembranous tracheitis.Table 2Infectious CausesNoninfectious Causes*Fungal*•Aspergillus species•Candida•Cryptococcus•Rhizopus•Mucorales*Bacterial*•Pseudomonas aeruginosa•Haemophilus influenza•Corynebacterium diphtheriae•Staphylococcal infections•a-hemolytic Streptococcus species•Moraxella catarrhalis•Bacillus cereus•Chlamydia species•Mycoplasma bovis•Pseudomembranous croup*Viral*•Bovine herpes virus1•Adenovirus•Influenza (co-infection)Smoke inhalation\
Endotracheal intubation\
Crohn disease\
Stevens-Johnson syndrome\
Agents of bioterrorism\
Ligneous conjunctivitis\
Paraquat ingestionAdapted from Patel et al. [@bib12].

Patients with pseudomembranous tracheitis typically present symptoms of dyspnea, fever, non-resolving cough, and chest pain. Dyspnea, as one of the presenting symptoms, is usually caused by the pseudomembrane obstructing the airways to the lungs [@bib11]. Colonies of fungi create plaques that line the bronchi which leads to a necrotizing bronchitis. Most common signs and symptoms of PMT are outlined in [Table 3](#tbl3){ref-type="table"}.Table 3Common symptoms of PMT.Table 3FeverDyspneaCoughChest painFatigueUnilateral wheeze

PMT is a rare condition, therefore a strong clinical suspicion is needed to diagnose this condition. Bronchoscopy is essential to discover pseudomembrane in the airways. A pseudomembrane has the potential to form and constrict the airways, thus causing the symptoms that are associated with PMT [@bib7]. Based on pathological tissue, brush smear, and fluid from bronchial that are obtained by a bronchoscopy, the results can lead to a diagnosis of airway aspergillus infection and the type of Aspergillus as well [@bib11]. In our case non resolution of infiltrates despite adequate antibiotic therapy prompted us to perform a bronchoscopy.

Since pseudomembranous tracheitis is mostly caused by fungal infection, a range of antifungal treatments would deem most effective towards the condition. [Table 1](#tbl1){ref-type="table"} suggests that amongst health care providers intravenous Amphotericin B is the initial treatment of choice [@bib11]. Other treatments such as voriconazole, itraconazole, and echinocandins (caspofungin) [@bib5], [@bib12] However recently, Voriconazole has been administered to patients with PMT due to its better prognosis, as shown in [Table 1](#tbl1){ref-type="table"}.

PMT has a high morbidity and mortality in immunosuppressed patients. This in itself lends to a high morbidity and mortality that is associated with opportunistic infections. It has been reported that death usually ensues between 1 and 6 weeks after diagnosis [@bib18]. Majority of cases of PMT have resulted in demise as demonstrated in [Table 1](#tbl1){ref-type="table"}. Some causes for death include respiratory failure, septic shock, or other organ failure. Respiratory failure in PMT may result from the pseudomembrane constricting the airways and can even dislodge thus creating a ball valve that leads to obstruction [@bib6], [@bib12].

4. Conclusion {#sec4}
=============

PMT is a rare condition that is mostly caused by fungal, and sometimes, bacterial infection. It usually requires a high index of suspicion for diagnosis. The prognosis depends on timely diagnosis and initiation of antifungal therapy.
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